Who Just RaisedResearch Triangle Park, NC · Health Care · Form D filed Sep 25, 2026
Dignify Therapeutics, LLC raised $800K
Dignify Therapeutics, LLC is a pharmaceutical company based in Research Triangle Park, North Carolina. In a Form D filed with the SEC on September 25, 2026, it reported raising $800,000 from 2 investors as part of an offering of up to $3,000,000. The first sale in the offering took place on September 15, 2026.
Restoring control of bowel and bladder function Clinical-Stage Company | FDA-Cleared IND | NIH-Funded Phase 1 | >$20M NIH Funding Who We Are Our Approach
- 2nd Form D since 2014. Earlier new notices: Oct 24, 2014. All filings on EDGAR
- Still raising. $2.2M of the $3M offering was still unsold at filing.
$800K raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 25, 2026 | $800K | $3M | 2 |
Lead score
31 out of 100
filed recently early raise still raising website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- dignifytherapeutics.com
- Amount raised
- $800,000
- Offering size
- $3,000,000
- Investors so far
- 2
- First sale
- September 15, 2026
- Securities offered
- Debt, Options or warrants, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Pharmaceuticals
- Headquarters
- Research Triangle Park, North Carolina
- Incorporated
- Delaware
- Entity type
- Limited Liability Company
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $800,000 | $3,000,000 | 2 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 21, 2026 · Health Care funding in North Carolina · September 2026 funding report
Similar raises
Aer Therapeutics, Inc.
Research Triangle Park, NC · filed Aug 19
AER Therapeutics is developing mucolytic treatments that target mucus plugs in COPD and asthma to improve lung function and quality of life.
3rd Form D since 2022
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Light Wave Ownership Path, LLC
Raleigh, NC · filed Oct 1512th Form D since 2019
Gradient Health, Inc.
Durham, NC · filed Oct 7
Access 20M+ de-identified patient journeys via Atlas - Gradient Health's AI healthcare data platform. Fast delivery for AI developers and research teams.
5th Form D since 2022
Toggle Bio
Durham, NC · filed Oct 6
Redefining fluorescent antibodies
First Form D
Swift Cardiovascular, Inc.
Durham, NC · filed Sep 24First Form DStill raising
Theia Imaging LLC
Durham, NC · filed Sep 17
Theia Imaging provides advanced ophthalmic imaging diagnostics accessible to populations unable to access conventional tabletop clinical imaging.
First Form DStill raising
Aclarity Genomics, Inc.
Morrisville, NC · filed Sep 2Multiomic solutions made easy. Featuring unmatched speed with whole genome and transcriptome amplification in as little as 30 minutes. try aclarity now Novel Problems Require Novel Solutions Our team…
First Form D